Cellebrite DI (NASDAQ:CLBT) Raised to Outperform at William Blair

William Blair upgraded shares of Cellebrite DI (NASDAQ:CLBT – Free Report) from a market perform rating to an outperform rating in a research note released on Wednesday morning, Marketbeat reports. A number of other brokerages also recently weighed in on CLBT. Needham & Company LLC lifted their target price on shares of Cellebrite DI from […]

Leave a Reply

Your email address will not be published.

Previous post New York Judge Delays Trump’s Criminal Trial Until At Least April
Next post Supermarket Income REIT’s (SUPR) Hold Rating Reiterated at Shore Capital